Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.5B | 13.6B | 11.9B | 14.8B |
Cost of revenue | 10.3B | 7.9B | 6.7B | 8.4B |
Gross profit | 7.2B | 5.7B | 5.3B | 6.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.4B | 2.1B | — | 2.9B |
Operating income | 1.4B | 1.3B | 2.9B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 1.1B | 1.1B | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 462.8M | 14.3M | -167.8M | 155.5M |
Tax provision | 184.2M | 26.5M | -36M | 33.2M |
Net income | 278.6M | -12.2M | -131.8M | 122.3M |
Basic EPS | — | 0.0 | -0.1 | 0.2 |
Diluted EPS | — | 0.0 | -0.1 | 0.2 |
Basic average shares | — | 687.5M | 707.9M | 679.5M |
Diluted average shares | — | 687.5M | 707.9M | 715.3M |
EBITDA | 2.3B | 1.8B | 1.5B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | 10.5M | 21.7M | 32.7M | 13.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |